Contract 75A50123F61004

Sanofi Vaccines Us Inc. · Department Of Health And Human Services · September 27, 2023

Firm Fixed PriceFull & Open CompetitionNAICS 541714IDIQ Task Order

Sanofi Vaccines Us Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2023 for $857.86 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Swiftwater, PA. This is a task or delivery order issued under parent IDIQ 75A50122D00003. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 17, 2025.

Obligated to date
$857.86M
$857,859,894
Current value
$38.4K
Modifications
5
Latest December 17, 2025

Contract details

PIID
75A50123F61004
Parent IDIQ
75A50122D00003
Award type
Delivery Order
Pricing
Firm Fixed Price
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
Health R&D Services; Health Care Services; Applied Research
Place of performance
Swiftwater, PA
First action
September 27, 2023
Latest action
December 17, 2025

Description

PROCURE STORAGE/ STABILITY OF H7N9 A/SHANGHAI FINAL CONTAINERS

Modification timeline

  • December 17, 2025
    Mod P00001 · Close Out
    $38.4K
  • November 5, 2025
    Mod P00008 · Other Administrative Action
    BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION
    $2.59M
  • July 10, 2025
    Mod P00007 · Supplemental Agreement For Work Within Scope
    BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION
    $2.59M
  • August 1, 2024
    Mod P00005 · Supplemental Agreement For Work Within Scope
    BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION
    $2.59M
  • September 28, 2023
    Base award
    OT TASK ORDER 4
    $855.60M
  • September 27, 2023
    Base award
    BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION
    $2.26M

Similar contracts

RecipientAgencyDateObligated
Vericel CorporationDepartment Of Health And Human ServicesApril 1, 2026$34.88M
American College Of Medical Toxicology, Inc.Department Of Health And Human ServicesMarch 31, 2026$0
Ceramedix Holding, LlcDepartment Of Health And Human ServicesMarch 31, 2026$4.22M
Glaxosmithkline, LlcDepartment Of Health And Human ServicesMarch 31, 2026$7.79M
Care Access Research LlcDepartment Of Health And Human ServicesMarch 31, 2026$2.55M
Pattern Bioscience, Inc.Department Of Health And Human ServicesMarch 31, 2026$22.50M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Amgen USA Inc1$59.99M
2Vericel Corporation1$34.88M
3Spectral Md, Inc.1$31.67M
4Ppd Development Lp6$31.12M
5L3 Technologies, Inc.1$22.00M
6Technical Resources International, Inc.6$21.80M
7Abbott Laboratories1$21.01M
8Paratek Pharmaceuticals, Inc1$17.47M
9Ossium Health, Inc.1$12.39M
10Rho Federal Systems Division Inc1$8.00M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50123F61004?

Contract 75A50123F61004 is a federal contract awarded to Sanofi Vaccines Us Inc. by Department Of Health And Human Services on September 27, 2023 for $857.86 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.

Who won contract 75A50123F61004?

Sanofi Vaccines Us Inc. won contract 75A50123F61004 from Department Of Health And Human Services.

How much is contract 75A50123F61004 worth?

Contract 75A50123F61004 has obligated $857.86 million to date.